Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.
about
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosisPalivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosisPalivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosisPalivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosisPalivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosisRespiratory viruses other than influenza virus: impact and therapeutic advancesHospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective studyA case-crossover study of wintertime ambient air pollution and infant bronchiolitis.Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosisPerinatal and early childhood environmental factors influencing allergic asthma immunopathogenesisBiomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severityDistinct RIG-I and MDA5 Signaling by RNA Viruses in Innate ImmunityHigh burden of RSV hospitalization in very young children: a data linkage study.Effect of point of care information on inpatient management of bronchiolitis.Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P.Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma.Respiratory syncytial virus surveillance in the United States, 2007-2012: results from a national surveillance systemIs the interpretation of rapid antigen testing for respiratory syncytial virus as simple as positive or negative?Reduced Dicer expression in the cord blood of infants admitted with severe respiratory syncytial virus disease.Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus.Immune responses and disease enhancement during respiratory syncytial virus infectionHousehold tobacco smoke and admission weight predict severe bronchiolitis in infants independent of deprivation: prospective cohort study.Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis.Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.Pharmacokinetics-pharmacodynamics of a respiratory syncytial virus fusion inhibitor in the cotton rat model.Association of RSV-related hospitalization and non-compliance with palivizumab among commercially insured infants: a retrospective claims analysis.Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults.Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis.Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected childrenRandomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis.Bordetella pertussis is an uncommon pathogen in children hospitalized with bronchiolitis during the winter season.Risk of urinary tract infection in infants and children with acute bronchiolitisVitamin D Levels Are Unrelated to the Severity of Respiratory Syncytial Virus Bronchiolitis Among Hospitalized Infants.Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants.Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virusDeterminants of asthma after severe respiratory syncytial virus bronchiolitis.Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infantsNational survey of pediatric services available in US emergency departmentsHuman genetic factors and respiratory syncytial virus disease severity.
P2860
Q24194584-8677532E-8945-4A35-AF0B-16F1A8676A2CQ24202211-20E32A64-21B6-4F8A-AF97-7155F8F975EBQ24203706-A96E0550-233A-48A3-BCF4-4569E0FC852BQ24240074-EB9061A8-7B71-4386-BE3D-D0BC58F4E1E5Q24240702-A2CA522B-01C3-47A1-8848-0DA76CC07B47Q24655957-CDB0593B-23C2-4A7F-AA80-40A6DBC07D66Q24803938-6BC31D25-9B5D-4359-9035-FEEF73AE6AB5Q25257486-A20DB89D-872C-46AC-8C51-012E47541A5FQ26471040-02A0CBC9-0938-49AF-ACAD-5FE28162E830Q26995085-82A3D3F8-73CF-499F-B0ED-C39F135B90DCQ27010165-0BDF8D5B-DC97-4A78-9ED0-05532076A79FQ27485306-C6274D34-78A7-45A4-AB98-B28696BB23C4Q31029754-2E214408-8BBB-41B1-B482-ECE46AD4B84DQ33270227-97C32FC8-348F-4302-9289-B37001C24309Q33302897-659A858E-1803-4263-9609-56860F39E5A2Q33605739-1C8DEAB4-248E-4B2E-8F99-A4D93CB6DE5FQ33630036-DE74764C-D178-494C-8810-A7E1B0B1C5D8Q33836095-3A320B4D-60DC-4EA7-8447-0A9E3B82BEDBQ33840252-E02F5E4D-AC57-40BE-854C-FC1943BE7675Q33859103-CEBD0316-F8FE-4AB1-A295-74A4D2CCE8FCQ33937152-47EB5010-7D40-4526-8997-46FBFF78D806Q33979970-AC56AA3C-2E26-472A-B188-6D1BFFEF5CF5Q34004492-43C47A88-9117-430E-9B57-20D863550CCCQ34057989-9ABB378F-F260-48BF-ACD1-4F5F7B42E7E9Q34290125-09990227-2E2D-408C-AC7D-BA9AD144B585Q34839654-93D473BE-764C-4546-BFA5-30BB49F1D94CQ35023114-FED365E7-B9E3-4343-8F79-8823B3FB20CDQ35107695-D8DE434C-C6DE-4073-8788-6B1EE1D1D11FQ35466073-D63545C0-620A-4284-905D-10B908EA2438Q35589481-8831ECE3-E907-445A-B19B-C09325C7C1F1Q35619610-2042B4EF-C8EE-4353-9241-1359A8F4D9A6Q35754968-63E6170F-38BB-4712-8800-1F6FC4887EC9Q36009649-F7247C75-F904-4EEA-B5F9-F9A286B35038Q36154485-4B18008E-1E1C-4E70-BE4A-4BD524A2E8F3Q36155439-04218D6E-9524-42F4-81C9-37DE491FD906Q36494613-9E2DEA83-D090-4A41-9C1F-A3131FC6AF5CQ36729353-C0C89053-A6E7-4050-9456-78F62C8B2023Q36764722-FD8C8912-2FCE-4A7F-AA84-84DC1A01BED5Q36805245-9C8AA92D-E9A9-4A5A-AD4A-2DCA55A72BA9Q36943137-18E663AE-1756-4C5A-AE29-F4BB64AD38A1
P2860
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.
@en
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.
@nl
type
label
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.
@en
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.
@nl
prefLabel
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.
@en
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.
@nl
P1476
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.
@en
P2093
Kimmie Kohlhase
Shelah Leader
P304
P356
10.1097/00006454-200207000-00005
P577
2002-07-01T00:00:00Z